Stock listing
Cynata Therapeutics Limited
Selected listing: 51S · FWB · EUR · DE
Cynata Therapeutics Limited (Frankfurt:51S), Health Technology. Latest release Oct 7, 2026: Cynata Receives R&D TI Refund & Repays R&D TI Loan.
- Ticker
- Frankfurt:51S
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
About Cynata Therapeutics Limited
The company focuses on developing innovative cell therapy solutions. Cynata is known for its proprietary Cymerus technology, which enables the production of large quantities of therapeutic cells.
Latest news from Cynata Therapeutics Limited
Research Cynata Therapeutics Limited
Cynata Therapeutics Limited company profile
View the public company page for Cynata Therapeutics Limited on 6ix.
Cynata Therapeutics Limited news
Read company news and market updates connected to Cynata Therapeutics Limited.
Cynata Therapeutics Limited investor events
Find investor webinars, events, and replay context for Cynata Therapeutics Limited.
Alternate listings
CYP:ASX
AU · AUD
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is 51S:FWB.
CYYNF:OTC
US · USD
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is 51S:FWB.
51S:HAM
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is 51S:FWB.
51S:MUN
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is 51S:FWB.
51S:SWB
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is 51S:FWB.